Literature DB >> 7647164

Dopamine D2 receptor gene (DRD2) haplotypes and the defense style questionnaire in substance abuse, Tourette syndrome, and controls.

D E Comings1, J MacMurray, P Johnson, G Dietz, D Muhleman.   

Abstract

The defence style questionnaire (DSQ) was administered to Caucasian males consisting of 123 subjects from a V.A. addiction treatment unit (ATU), 42 Tourette syndrome (TS) subjects, and 49 controls. For the ATU and TS subjects, there was a significant decrease in the mean score for mature defenses and a significant increase in mean score for immature defenses compared to controls. Many of the individual subscores showed the same significant differences. Dopamine D2 receptor (DRD2) gene haplotypes, identified by allele specific polymerase chain reaction of two mutations (G/T and C/T) 241 base pairs apart, were determined in 57 of the ATU subjects and 42 of the controls. Subjects with the 1 haplotype tended to show a decrease in mature and an increase in neurotic and immature defense styles compared to those without the 1 haplotype. Of the eight times that the subscale scores were significant for haplotype 1 versus non-1, they were always in this direction. There results suggest that the DRD2 locus is one factors controlling defense styles. The difference in the mean scores between controls and substance abuse subjects indicates that other genes and environmental factors also play a role.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7647164     DOI: 10.1016/0006-3223(94)00222-O

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  9 in total

1.  Hypothesizing dopaminergic genetic antecedents in schizophrenia and substance seeking behavior.

Authors:  Kenneth Blum; Marlene Oscar-Berman; Rajendra D Badgaiyan; Tomas Palomo; Mark S Gold
Journal:  Med Hypotheses       Date:  2014-02-26       Impact factor: 1.538

2.  Comorbid migraine with aura, anxiety, and depression is associated with dopamine D2 receptor (DRD2) NcoI alleles.

Authors:  S J Peroutka; S C Price; T L Wilhoit; K W Jones
Journal:  Mol Med       Date:  1998-01       Impact factor: 6.354

3.  Proposing a "Brain Health Checkup (BHC)" as a Global Potential "Standard of Care" to Overcome Reward Dysregulation in Primary Care Medicine: Coupling Genetic Risk Testing and Induction of "Dopamine Homeostasis".

Authors:  Eric R Braverman; Catherine A Dennen; Mark S Gold; Abdalla Bowirrat; Ashim Gupta; David Baron; A Kenison Roy; David E Smith; Jean Lud Cadet; Kenneth Blum
Journal:  Int J Environ Res Public Health       Date:  2022-04-30       Impact factor: 4.614

Review 4.  Neurogenetics of dopaminergic receptor supersensitivity in activation of brain reward circuitry and relapse: proposing "deprivation-amplification relapse therapy" (DART).

Authors:  Kenneth Blum; Thomas J H Chen; B William Downs; Abdalla Bowirrat; Roger L Waite; Eric R Braverman; Margaret Madigan; Marlene Oscar-Berman; Nicholas DiNubile; Eric Stice; John Giordano; Siobhan Morse; Mark Gold
Journal:  Postgrad Med       Date:  2009-11       Impact factor: 3.840

5.  Neuropsychiatric Genetics of Happiness, Friendships, and Politics: Hypothesizing Homophily ("Birds of a Feather Flock Together") as a Function of Reward Gene Polymorphisms.

Authors:  Kenneth Blum; Marlene Oscar-Berman; Abdalla Bowirrat; John Giordano; Margaret Madigan; Eric R Braverman; Debmayla Barh; Mary Hauser; Joan Borsten; Thomas Simpatico
Journal:  J Genet Syndr Gene Ther       Date:  2012-04-13

6.  Association between PPP1R1B polymorphisms and defense mechanisms in healthy Chinese-Han subjects.

Authors:  Yinglin Huang; Jingying Li; Hui Ma; Xiaofeng Zhao; Yuan Wang; Qiu Jin; Bo Zhang; Lijuan Wu; Huan Ma; Gang Zhu
Journal:  J Mol Neurosci       Date:  2012-10-19       Impact factor: 3.444

7.  Long term Suboxone™ emotional reactivity as measured by automatic detection in speech.

Authors:  Edward Hill; David Han; Pierre Dumouchel; Najim Dehak; Thomas Quatieri; Charles Moehs; Marlene Oscar-Berman; John Giordano; Thomas Simpatico; Debmalya Barh; Kenneth Blum
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

8.  The Molecular Neurobiology of Twelve Steps Program & Fellowship: Connecting the Dots for Recovery.

Authors:  Kenneth Blum; Benjamin Thompson; Zsolt Demotrovics; John Femino; John Giordano; Marlene Oscar-Berman; Scott Teitelbaum; David E Smith; A Kennison Roy; Gozde Agan; James Fratantonio; Rajendra D Badgaiyan; Mark S Gold
Journal:  J Reward Defic Syndr       Date:  2015

9.  Systematic evaluation of "compliance" to prescribed treatment medications and "abstinence" from psychoactive drug abuse in chemical dependence programs: data from the comprehensive analysis of reported drugs.

Authors:  Kenneth Blum; David Han; John Femino; David E Smith; Scott Saunders; Thomas Simpatico; Stephen J Schoenthaler; Marlene Oscar-Berman; Mark S Gold
Journal:  PLoS One       Date:  2014-09-23       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.